Glenn Braunstein: Research highlights from 2022 in thyroid disorders

We caught up with the American Thyroid Association (ATA) president Prof. Julie Ann Sosa, MD, MA, FACS (University of California, San Francisco, CA, USA) ahead of this year’s virtual meeting to highlight their ATA Centennial Celebration at their upcoming conference taking place in Washington, DC in 2023. The 2023 American Thyroid Association Annual Meetings Centennial […]

There has also been high interest in the treatment of hypothyroidism in older adults, the treatment of thyroid eye disease and the increase of radiofrequency ablation for thyroid nodules to reduce their size by 50% to 97%. We were delighted to speak with our editorial board member Prof. Glenn Braunstein (Cedars-Sinai Medical Center, Los Angeles, […]

Current evidence indicates cardio‐metabolic effects from antithyroid drugs and other definitive treatment options for hyperthyroidism. The EGRET study aimed to assess the differences in mortality and cardiometabolic outcomes depending on the method of treatment in order to better inform patient‐clinician decision‐making. In this touchENDOCRINOLOGY interview, Prof. Kristien Boelaert (University of Birmingham, Birmingham, United Kingdom) discusses […]